Ocuphire Pharma

$7.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.16 (+2.30%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell OCUP and other stocks, options, and ETFs commission-free!

About OCUP

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI. The listed name for OCUP is Ocuphire Pharma, Inc. Common Stock.

CEO
Mina Patel Sooch
Employees
5
Headquarters
Farmington Hills, Michigan
Founded
2018
Market Cap
79.54M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
71.61K
High Today
$7.21
Low Today
$6.62
Open Price
$7.13
Volume
54.71K
52 Week High
$17.04
52 Week Low
$3.68

Collections

OCUP Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 19, Pre-Market

You May Also Like

HTRB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure